This ensures results are safe, consistent, and tailored to each individuals goals
Larger and longer studies in broader populations are needed to fully understand the safety and efficacy in people with alcohol use disorder, but these initial findings are promising. About this study: In addition to Hendershot and Klein, other authors of the study are Michael Bremmer, Michael Paladino, Georgios Kostantinis, Thomas Gilmore, Neil Sullivan, Amanda Tow and Robyn Jordan, all of University of North Carolina at Chapel Hill
Dysbiosis impairs incretin signaling, reducing the effectiveness of GLP-1 therapies
We help tailor frequency based on how you feel and what you want to support long term
Your body should adjust to glutathione treatment within a few days, but side effects can last longer in some individuals
Regulatory approvals for weight management indications, including expanded labels for cardiovascular risk reduction in overweight adults, have unlocked primary care prescribing and direct-to-consumer demand